(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

MUSPAGDU

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

MUSPAGDU

ST13

US500000079249249

Class

5

Filing

79249249

Registration

5836981

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

27

Latest update

03/31/2026

Trademark type

Word

Nice classes

5

Filing date

09/03/2018

Registration date

08/20/2019

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/06/2026

Last transaction

03/31/2026

Responsible office

United States Patent and Trademark Office

Status code

709

Official register

Principal Register

Drawing code

4

Owner type

03

Owner location

JP

Examiner

O'BRIEN, JENNIFER LYNN

Law office

N20

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

TAIHO PHARMACEUTICAL CO., LTD.

Representatives

Howard N. Aronson Lackenbach Siegel, LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for the treatment of tumor; pharmaceutical preparations for the treatment of cancer; chemical reagents for medical purposes in the field of oncology; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical preparations for the treatment of dermatological diseases and disorders; pharmaceutical preparations for the treatment of muscular diseases and disorders; pharmaceutical preparations for the treatment of urological diseases and disorders; pharmaceutical preparations for the treatment of digestive diseases and disorders; pharmaceutical preparations for the treatment of gastroesophageal reflux diseases and disorders; pharmaceutical preparations for the treatment of hepatic diseases and disorders; pharmaceutical preparations for the treatment of renal diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of diseases of the central and peripheral nervous system; pharmaceutical preparations for the treatment of rheumatoid arthritis; pharmaceutical preparations for the treatment of diseases of the blood; pharmaceutical preparations for the treatment of allergies; pharmaceutical preparations for use in chemotherapy; anti-emetic medicines; pharmaceutical preparations for the treatment of pain; analgesic preparations; antiphlogistic preparationspharmaceutical preparations for the treatment of inflammation

Publications

History of USPTO decisions and trademark events.

27 publications found

C71T

CANCELLED SECTION 71

03/06/2026

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

08/20/2024

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

01/03/2020

FICS

FINAL DISPOSITION NOTICE SENT TO IB

12/13/2019

FIMP

FINAL DISPOSITION PROCESSED

12/13/2019

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

11/20/2019

R.PR

REGISTERED-PRINCIPAL REGISTER

08/20/2019

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/04/2019

PUBO

PUBLISHED FOR OPPOSITION

06/04/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/15/2019

ALIE

ASSIGNED TO LIE

04/26/2019

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/16/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/25/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/25/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/25/2019

CORN

CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED

02/26/2019

RFNP

REFUSAL PROCESSED BY IB

02/22/2019

CRCV

CORRECTION TRANSACTION RECEIVED FROM IB

02/15/2019

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

02/04/2019

RFRR

REFUSAL PROCESSED BY MPU

02/04/2019

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

01/23/2019

CNRT

NON-FINAL ACTION WRITTEN

01/22/2019

MAFR

APPLICATION FILING RECEIPT MAILED

01/19/2019

DOCK

ASSIGNED TO EXAMINER

01/15/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/15/2019

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

01/14/2019

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

01/10/2019

Continuous trademark protection

Get notified about every new filing that threatens MUSPAGDU or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.